AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

Not Applicable

Active, not recruiting

Conditions: Low or Intermediate Risk Prostate Cancer

Interventions: Procedure: Advanced imaging for radiotherapy planning and guidance

First Posted Date: 2009-04-29

Last Posted Date: 2025-02-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 99

Registration Number: NCT00890006

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer

Phase 1

Terminated

Conditions: Epithelial Ovarian Cancer

Interventions: Drug: Intraperitoneal (IP) Cisplatin

First Posted Date: 2009-04-29

Last Posted Date: 2024-03-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 9

Registration Number: NCT00889733

Locations: 🇨🇦
University Health Network - Princess Margaret Hospital, Toronto, Ontario, Canada

Positron Emission Tomography(PET) in Lymphoma Assessment

Not Applicable

Completed

Conditions: Hodgkin's Lymphoma
Non Hodgkin's Lymphoma

Interventions: Biological: PET Scan

First Posted Date: 2009-04-24

Last Posted Date: 2012-12-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 103

Registration Number: NCT00887718

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Phase 2

Completed

Conditions: Adenoid Cystic Carcinoma
Salivary Gland Cancer

Interventions: Drug: Sunitinib

First Posted Date: 2009-04-22

Last Posted Date: 2015-07-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 14

Registration Number: NCT00886132

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

A Study of Pre-operative Metformin in Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Metformin

First Posted Date: 2009-04-15

Last Posted Date: 2012-06-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 24

Registration Number: NCT00881725

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection: A Proof of Concept Pilot Study

Phase 1

Completed

Conditions: Kidney Injury

Interventions: Other: Advanced red blood cell transfusion

First Posted Date: 2009-03-13

Last Posted Date: 2013-02-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT00861822

Locations: 🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Phase 3

Completed

Conditions: HIV Infection
Herpes Simplex Type II
HIV Infections

Interventions: Drug: valacyclovir
Drug: Placebo

First Posted Date: 2009-03-13

Last Posted Date: 2018-03-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 202

Registration Number: NCT00860977

Locations: 🇨🇦
McMaster University Health Sciences Centre, Hamilton, Ontario, Canada
🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
🇨🇦
University of Ottawa Health Services, Ottawa, Ontario, Canada

and more 22 locations

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

Phase 2

Completed

Conditions: Cancer of the Prostate
Prostate Cancer
Prostatic Neoplasms

Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E
Drug: Placebo

First Posted Date: 2009-02-16

Last Posted Date: 2017-10-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 48

Registration Number: NCT00844792

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma

Phase 2

Completed

Conditions: Pheochromocytoma
Paraganglioma

Interventions: Drug: Sunitinib

First Posted Date: 2009-02-13

Last Posted Date: 2024-10-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 25

Registration Number: NCT00843037

Locations: 🇳🇱
University Medical Centre Groningen, Groningen, Netherlands
🇨🇦
University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada

and more 1 locations

Internet-Based Strategic Transdisciplinary Approach To Risk Reduction And Treatment

Phase 2

Completed

Conditions: Hypertension

Interventions: Behavioral: Generic Information
Behavioral: Web-based lifestyle counseling messages

First Posted Date: 2008-12-30

Last Posted Date: 2012-02-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 387

Registration Number: NCT00815477

Locations: 🇨🇦
Grey Bruce Public Health Unit, Owen Sound, Ontario, Canada
🇨🇦
University of Western Ontario, London, Ontario, Canada
🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Home Terms & Conditions Privacy Policy